Clinuvel Pharmaceuticals Financial Overview
Clinuvel Pharmaceuticals 's market cap is currently AU$618.98M. The company's EPS TTM is AU$0.439; its P/E ratio is 17.07; and it has a dividend yield of 0.38%. Clinuvel Pharmaceuticals is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is AU$0.28. See an overview of income statement, balance sheet, and cash flow financials.
